The Broad Institute of MIT and Harvard is an independent research institution dedicated to accelerating the pace at which the world conquers disease.
Our Mission
The Broad Institute pursues high-impact projects focused on major challenges in biomedicine.
Private philanthropy has played a critical role at the Broad Institute from the very beginning.
Studies led by Broad scientists have revealed some of the strongest genetic risk factors for schizophrenia and bipolar disorder.
A rheumatologist and Broad scientist seeks to improve the precision of diagnoses for immune disorders.
Dr. Richard Merkin continues his decade-long legacy of supporting powerful technological approaches aimed at the treatment of disease.